Open access
64
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies
Craig LaForce1 NC Clinical Research, Raleigh, NC, USACorrespondence[email protected]
, Eric Derom2 Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
, Ulrich Bothner3 Pharmacovigilance, Boehringer Ingelheim International GmbH, Ingelheim, Germany
, Isabel M Kloer3 Pharmacovigilance, Boehringer Ingelheim International GmbH, Ingelheim, Germany
, Matthias Trampisch4 Biostatistics & Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
& Roland Buhl5 Pulmonary Department, Mainz University Hospital, Mainz, Germany
Pages 1819-1831
|
Published online: 01 Jun 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.